You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm

€3.03

SKU: product-article-44295 Category: General

Description
Reviews (0)

Description

Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm

Reviews

There are no reviews yet.

Be the first to review “Article: Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm”

You must be logged in to post a review.

Top

Article: Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm

Description

Reviews

Related products

Article: Highlights in breast cancer

Article: Highlights in melanoma

Article: Highlights in breast cancer

Article: Highlights in gynaecological cancers